These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24813044)

  • 21. The diagnosis and treatment of attention deficit-hyperactivity disorder in children and adolescents with cystic fibrosis: a retrospective study.
    Georgiopoulos AM; Hua LL
    Psychosomatics; 2011; 52(2):160-6. PubMed ID: 21397109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
    Janols LO; Liliemark J; Klintberg K; von Knorring AL
    Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADHD interventions in children younger than six years.
    Salisbury-Afshar E
    Am Fam Physician; 2013 Aug; 88(4):266-8. PubMed ID: 23944731
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical practice. Attention deficit-hyperactivity disorder.
    Rappley MD
    N Engl J Med; 2005 Jan; 352(2):165-73. PubMed ID: 15647579
    [No Abstract]   [Full Text] [Related]  

  • 25. Attention deficit hyperactivity disorder: part III.
    Ryan-Krause P
    J Pediatr Health Care; 2011; 25(1):50-6. PubMed ID: 21147408
    [No Abstract]   [Full Text] [Related]  

  • 26. The management of patients with attention-deficit hyperactivity disorder by family practitioners.
    Eppright TD; Bradley S; Vogel SJ; Williamson HA
    Mo Med; 1998 Mar; 95(3):118-22. PubMed ID: 9529896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 28. Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood.
    Barkley RA
    Postgrad Med; 2008 Sep; 120(3):48-59. PubMed ID: 18824825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term courses in children with attention deficit hyperactivity disorder (ADHD)].
    Huss M
    MMW Fortschr Med; 2004 Mar; 146(12):36-7, 39. PubMed ID: 15357502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder.
    Rader R; McCauley L; Callen EC
    Am Fam Physician; 2009 Apr; 79(8):657-65. PubMed ID: 19405409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychosocial treatments for attention-deficit/hyperactivity disorder in children.
    Barkley RA
    J Clin Psychiatry; 2002; 63 Suppl 12():36-43. PubMed ID: 12562060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attention-deficit/hyperactivity disorder: a personal perspective.
    Ginsberg ML
    Adolesc Med State Art Rev; 2008 Aug; 19(2):339-51, xi-xii. PubMed ID: 18822837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attention-deficit/hyperactivity disorder.
    Joughin C; Ramchandani P; Zwi M
    Am Fam Physician; 2003 May; 67(9):1969-70. PubMed ID: 12751659
    [No Abstract]   [Full Text] [Related]  

  • 34. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
    Gadow KD; Sverd J
    Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
    [No Abstract]   [Full Text] [Related]  

  • 35. Treating children with attention-deficit hyperactivity disorder.
    Rapport MD
    Behav Modif; 1992 Apr; 16(2):155-63. PubMed ID: 1349808
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacotherapy in ADHD. Guidelines for prescribing stimulant medications in young children.
    August GJ; Realmuto GM
    Minn Med; 2000 Jun; 83(6):45-6. PubMed ID: 10881573
    [No Abstract]   [Full Text] [Related]  

  • 37. Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.
    Noorbala AA; Akhondzadeh S
    Arch Iran Med; 2006 Oct; 9(4):374-80. PubMed ID: 17061613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic treatment of attention deficit hyperactivity disorder.
    Greenhill LL
    Psychiatr Clin North Am; 1992 Mar; 15(1):1-27. PubMed ID: 1347936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S; Prins PJ; Oosterlaan J; Emmelkamp PM
    Clin Psychol Psychother; 2012; 19(3):270-8. PubMed ID: 21404369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neurological basis of attention deficit hyperactivity disorder.
    Ballard S; Bolan M; Burton M; Snyder S; Pasterczyk-Seabolt C; Martin D
    Adolescence; 1997; 32(128):855-62. PubMed ID: 9426808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.